Published in Ann Am Thorac Soc on February 01, 2016
Interstitial Photodynamic Therapy-A Focused Review. Cancers (Basel) (2017) 0.77
Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors. Oral Oncol (2016) 0.75
Size-Tunable Gd2O3@Albumin Nanoparticles Conjugating Chlorin e6 for Magnetic Resonance Imaging-Guided Photo-Induced Therapy. Theranostics (2017) 0.75
Endobronchial ultrasound-guidance for interstitial photodynamic therapy of locally advanced lung cancer-a new interventional concept. J Thorac Dis (2017) 0.75
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med (2012) 35.24
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Natural innate and adaptive immunity to cancer. Annu Rev Immunol (2011) 7.09
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Lancet Oncol (2015) 5.95
How does photodynamic therapy work? Photochem Photobiol (1992) 4.49
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody. Clin Cancer Res (2012) 3.68
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J (2012) 2.45
The physics, biophysics and technology of photodynamic therapy. Phys Med Biol (2008) 2.22
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur Respir J (2006) 2.04
A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol (1993) 2.02
Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. J Clin Oncol (2011) 1.93
Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol (2004) 1.93
Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc (1997) 1.91
Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res (2009) 1.80
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg (2003) 1.66
Microscopic residual disease after resection for lung cancer: a multifaceted but poor factor of prognosis. Ann Thorac Surg (2010) 1.62
An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res (1997) 1.60
Photodynamic therapy for cancer of the pancreas. Gut (2002) 1.51
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother (2011) 1.51
The effect of Radachlorin® PDT in advanced NSCLC: a pilot study. Photodiagnosis Photodyn Ther (2013) 1.40
Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol (2009) 1.39
The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res (1996) 1.35
Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer (2003) 1.33
Endobronchial photodynamic therapy for lung cancer. Lasers Surg Med (2006) 1.31
Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer. Lasers Surg Med (2006) 1.29
Photodynamic therapy for endobronchial malignant disease: a prospective fourteen-year study. J Thorac Cardiovasc Surg (1997) 1.29
Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. Lancet Oncol (2007) 1.29
Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res (2001) 1.26
Vascular effects of photodynamic therapy. Anticancer Res (2002) 1.21
Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg (2012) 1.18
Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol (2005) 1.18
Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate. Med Phys (2007) 1.17
Photodynamic therapy and anti-tumor immunity. Lasers Surg Med (2006) 1.17
Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett (1999) 1.14
Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11
Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res (2004) 1.09
Cross-linking of signal transducer and activator of transcription 3--a molecular marker for the photodynamic reaction in cells and tumors. Clin Cancer Res (2007) 1.08
Outcome of photodynamic therapy using NPe6 for bronchogenic carcinomas in central airways >1.0 cm in diameter. Clin Cancer Res (2010) 1.07
Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis. J Thorac Cardiovasc Surg (2009) 1.06
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin Cancer Res (1996) 1.05
Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer (1997) 1.02
Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation (2004) 1.02
ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. Photochem Photobiol Sci (2014) 1.01
Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells. Cancer Res (2004) 1.01
Photodynamic therapy enhancement of anti-tumor immunity. Photochem Photobiol Sci (2011) 1.00
Photodynamic therapy for the treatment of non-small cell lung cancer. J Thorac Dis (2012) 0.99
Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer (1994) 0.98
Immune checkpoint modulation for non-small cell lung cancer. Clin Cancer Res (2015) 0.97
Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc (1987) 0.97
System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer. J Biomed Opt (2010) 0.96
Recurrence after surgery in patients with NSCLC. Transl Lung Cancer Res (2014) 0.95
Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy. Lung Cancer (2007) 0.95
Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunol Immunother (2008) 0.93
Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin Cancer Res (2013) 0.92
Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin Oncol (2014) 0.92
mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol (2001) 0.92
In vivo photosensitizer tomography inside the human prostate. Opt Lett (2009) 0.91
The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg (1999) 0.91
Locally recurrent central-type early stage lung cancer < 1.0 cm in diameter after complete remission by photodynamic therapy. Chest (2005) 0.90
The rates and CT patterns of locoregional recurrence after resection surgery of lung cancer: correlation with histopathology and tumor staging. J Thorac Imaging (2003) 0.90
Management of multiple primary lung cancer in patients with centrally located early cancer lesions. J Thorac Oncol (2010) 0.90
Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer (2009) 0.90
Results of long-term follow-up of photodynamic therapy for roentgenographically occult bronchogenic squamous cell carcinoma. Chest (2009) 0.89
Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med (2007) 0.89
Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax (2006) 0.89
Photodynamic therapy for peripheral lung cancer. Lung Cancer (2004) 0.89
Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen. Br J Cancer (2013) 0.88
Fluorescence bronchoscopy for detection of lung cancer. Chest (1979) 0.88
Photodynamic therapy (PDT) of lung cancer: experience of the Tokyo Medical University. Photodiagnosis Photodyn Ther (2004) 0.87
A new finite element approach for near real-time simulation of light propagation in locally advanced head and neck tumors. Lasers Surg Med (2015) 0.87
Adjuvant intraoperative photodynamic therapy in head and neck cancer. JAMA Otolaryngol Head Neck Surg (2013) 0.86
Hematoporphyrin derivative photodynamic therapy in roentgenographically occult carcinoma of the tracheobronchial tree. Cancer (1992) 0.86
Lung cancers treated with photodynamic therapy and surgery. Diagn Ther Endosc (1999) 0.85
Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells. Photochem Photobiol (2011) 0.85
Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer. Cancer Biol Ther (2012) 0.85
Therapeutic bronchoscopy in lung cancer. Laser therapy, electrocautery, brachytherapy, stents, and photodynamic therapy. Clin Chest Med (2002) 0.84
Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer. Lasers Surg Med (2006) 0.84
Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma. Ann Cardiothorac Surg (2012) 0.84
Role of photodynamic therapy in unresectable esophageal and lung cancer. Lasers Surg Med (2006) 0.83
Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer. Photodiagnosis Photodyn Ther (2014) 0.82
Photodynamic laser therapy for lesions in the airway. Ann Thorac Surg (2010) 0.82
Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection. Photochem Photobiol (2008) 0.82
Photodynamic therapy (PDT) for lung cancer. Photodiagnosis Photodyn Ther (2011) 0.81
Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer--a clinical pilot study. Lasers Surg Med (2001) 0.81
Photodynamic therapy for patients with advanced non-small-cell carcinoma of the lung. Clin Lung Cancer (2001) 0.80
Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (clinical pilot study in 40 patients). Eur J Cardiothorac Surg (2001) 0.80
Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). Photodiagnosis Photodyn Ther (2009) 0.80
Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest (1990) 0.80
[Preoperative photodynamic therapy for lung cancer]. Nihon Geka Gakkai Zasshi (2000) 0.79
Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity. Front Oncol (2015) 0.78
MR and CT based treatment planning for mTHPC mediated interstitial photodynamic therapy of head and neck cancer: description of the method. Lasers Surg Med (2013) 0.78
[Short term result of lung cancer treated by photodynamic therapy (PDT)]. Zhonghua Zhong Liu Za Zhi (1987) 0.78
[Use of endotracheobronchial surgery in conjunction with radiochemotherapy for advanced non-small lung cancer]. Vopr Onkol (2007) 0.78
Application of hematoporphyrin derivative and laser-induced photodynamical reaction in the treatment of lung cancer: a preliminary report on 21 cases. Lasers Surg Med (1984) 0.78
Pleural Photodynamic Therapy and Surgery in Lung Cancer and Thymoma Patients with Pleural Spread. PLoS One (2015) 0.77
[Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser]. Gan To Kagaku Ryoho (1993) 0.77
Hematoporphyrin-derivative phototherapy for local treatment of cancer of the tracheobronchial tree. Ann Otol Rhinol Laryngol (1983) 0.77
[Photodynamic therapy in treatment of lung cancer]. Vestn Khir Im I I Grek (2010) 0.77